Aquinox Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Aquinox Pharmaceuticals Inc
TickerNGNE
CIK #0001404644
CUSIP64135M105
SectorLife Sciences - Pharmaceutical Preparations
Address887 Great Northern Way Suite 450, Vancouver, BC V5T 4T5
Source [EDGAR]
CIK Filing 2011 - 2025
[0001404644] 10-K
[0001404644] 10-Q
[0001404644] 3
[0001404644] 4
[0001404644] 5
[0001404644] 8-K
[0001404644] D
[0001404644] SC 13D
[0001404644] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Baker Bros Advisors LP Neurogene Inc [2025-05-15] 0.0
Commodore Capital LP Neurogene Inc [2024-12-11] 5.4
RTW Investments LP Neurogene Inc [2024-11-14] 8.7
FMR LLC Neurogene Inc [2024-11-12] 0.0
Casdin Capital LLC Neurogene Inc [2024-11-08] 6.9
BlackRock Inc Neurogene Inc [2024-07-08] 10.7
Samsara Biocapital LP Neurogene Inc [2024-02-14] 0.99
Cormorant Asset Management LP Neurogene Inc [2024-02-14] 1.21
EcoR1 Capital LLC Neurogene Inc [2024-02-14] 0.99
Janus Henderson Group PLC Neurogene Inc [2024-02-14] 6.6
Great Point Partners LLC Neurogene Inc [2023-12-27] 7.56
McMinn Rachel Neurogene Inc [2023-12-21] 0.9
Redmile Group LLC Neoleukin Therapeutics Inc [2023-07-27] 6.6
Pictet Asset Management Sa Neoleukin Therapeutics Inc [2023-02-03] 0.0
Lynx1 Capital Management LP Neoleukin Therapeutics Inc [2022-12-30] 5.38
Millennium Management LLC Neoleukin Therapeutics Inc [2022-07-19] 5.0
Millennium Management LLC Neoleukin Therapeutics Inc [2022-07-15] 4.97
BlackRock Inc Neoleukin Therapeutics Inc [2022-07-08] 2.1
Millennium Management LLC Neoleukin Therapeutics Inc [2022-07-07] 4.98
Pictet Asset Management Sa Neoleukin Therapeutics Inc [2022-02-10] 6.07
Redmile Group LLC Neoleukin Therapeutics Inc [2021-02-16] 0.9
Silva Manzano Daniel Adriano Neoleukin Therapeutics Inc [2021-02-12] 6.96
ULGE UMUT Neoleukin Therapeutics Inc [2021-02-12] 6.98
BlackRock Inc Neoleukin Therapeutics Inc [2021-02-02] 6.4
Silva Manzano Daniel Adriano Neoleukin Therapeutics Inc [2020-02-13] 8.2
ULGE UMUT Neoleukin Therapeutics Inc [2020-02-13] 8.2
Drachman Jonathan G Neoleukin Therapeutics Inc [2019-12-27] 5.8
EcoR1 Capital LLC Neoleukin Therapeutics Inc [2019-12-27] 8.1
EcoR1 Capital LLC Aquinox Pharmaceuticals Inc [2018-07-16] 7.5
Price T Rowe Associates Inc /MD/ Aquinox Pharmaceuticals Inc [2016-10-11] 14.4
Ventures West 8 Limited Partnership Aquinox Pharmaceuticals Inc [2016-02-16] 5.93
BlackRock Inc Aquinox Pharmaceuticals Inc [2016-01-28] 5.3
Visium Asset Management LP Aquinox Pharmaceuticals Inc [2015-09-21] 8.6
RA Capital Management LLC Aquinox Pharmaceuticals Inc [2015-08-24] 0.6
Baker Bros Advisors LP Aquinox Pharmaceuticals Inc [2015-08-10] 39.8
Augment Investments Ltd Aquinox Pharmaceuticals Inc [2015-02-12] 5.3
Ventures West 8 Limited Partnership Aquinox Pharmaceuticals Inc [2015-02-11] 14.1
Franklin Resources Inc Aquinox Pharmaceuticals Inc [2015-02-09] 5.5
Johnson & Johnson Aquinox Pharmaceuticals Inc [2015-02-06] 15.1
Baker Bros Advisors LP Aquinox Pharmaceuticals Inc [2014-04-10] 12.1
Pfizer Inc Aquinox Pharmaceuticals Inc [2014-03-21] 9.0
Form 3/4/5 Filer 2011 - 2025
Neurogene Inc.
Woods Robert Keith
Noonberg Sarah B.
Freedland Cory S.
Palekar Rohan
Baffi Robert
Cobb Stuart
McMinn Rachel
Cvijic Christine Mikail
Jordan Julie
Akkaraju Srinivas
Samsara BioCapital GP, LLC
Samsara BioCapital, L.P.
Baker Bros Advisors LP
667 LP
Baker Felix
Baker Brothers Life Sciences LP
Baker Bros. Advisors (GP) LLC
Baker Julian
Smith Sean Michael
Babler Martin
Lavelle Erin
Simpson Todd E
Patel Priti
Drachman Jonathan G
Cochener Donna
Walkey Carl
Ho Robert
Vance Holly
Williams Lewis T
Lavelle Erin M.
Nolan Sean P.
Redmile Group, LLC
Green Jeremy
Boyd Meta Cantey
Alam Kamran
McCloskey Shelley
MacKenzie Lloyd
Main David
Levitt Daniel J
Bridger Gary
Pelzer Robert
Troupin Barbara
Jenkins Abigail
Neu Kelvin
Levy Richard S
Mitchell David Chilton
Shrewsbury Stephen B
Pfizer Inc
Johnson & Johnson
Johnson & Johnson Innovation - JJDC, Inc.
Ventures West 8 Limited Partnership
Jones Elaine V
Form 13F Holdings
Firm Period DFND Voting Shares
Samsara Biocapital LLC [2025-06-30] SOLE 1,717,127 1,717,127
RTW Investments LP [2025-06-30] SOLE 1,362,456 1,362,456
Casdin Capital LLC [2025-06-30] SOLE 1,295,361 1,295,361
Redmile Group LLC [2025-06-30] SOLE 1,276,676 1,276,676
EcoR1 Capital LLC [2025-06-30] SOLE 1,271,342 1,271,342
Baker Bros Advisors LP [2025-06-30] SOLE 991,691 991,691
BlackRock, Inc. [2025-06-30] SOLE 957,886 977,682
Toronto Dominion Bank [2025-06-30] DFND 0 681,337
Vanguard Group Inc [2025-06-30] SOLE 0 603,115
ArrowMark Colorado Holdings LLC [2025-06-30] SOLE 585,397 585,397
Morgan Stanley [2025-06-30] DFND 543,106 545,603
Great Point Partners LLC [2025-06-30] SOLE 0 485,859
FMR LLC [2025-06-30] DFND 468,042 468,476
Commodore Capital LP [2025-06-30] SOLE 427,866 427,866
Millennium Management LLC [2025-06-30] SOLE 307,805 307,805
Octagon Capital Advisors LP [2025-06-30] SOLE 303,000 303,000
Geode Capital Management LLC [2025-06-30] DFND 247,775 247,775
UBS Group AG [2025-06-30] DFND 236,002 240,319
State Street Corp [2025-06-30] DFND 196,348 210,848
Jennison Associates LLC [2025-06-30] DFND 167,563 167,563
Deutsche Bank AG [2025-06-30] DFND 62,363 151,119
Susquehanna International Group LLP [2025-06-30] OTR 26,006 150,106
Blair William & Co/IL [2025-06-30] SOLE 87,916 133,236
Rock Springs Capital Management LP [2025-06-30] SOLE 104,339 104,339
Bank of America Corp /DE/ [2025-06-30] DFND 1,900 95,401
Northern Trust Corp [2025-06-30] DFND 91,572 91,572
Woodline Partners LP [2025-06-30] SOLE 83,835 83,835
DAFNA Capital Management LLC [2025-06-30] SOLE 51,096 51,096
Wellington Management Group LLP [2025-06-30] DFND 0 44,904
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM [2025-06-30] DFND 34,761 34,761
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com